Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial

@article{Perriello2005InsulinAI,
  title={Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial},
  author={G. Perriello and S. Pampanelli and F. Porcellati and A. Avogaro and E. Bosi and G. Petrella and S. Squatrito and S. Furneri and G. Marra and L. Vitali and M. Previti and D. Cucinotta},
  journal={Diabetic Medicine},
  year={2005},
  volume={22}
}
Aims  This randomized, multi‐centre, double‐blind, stratified, two period, cross‐over trial was undertaken to assess the pharmacokinetics and pharmacodynamics of insulin aspart injected immediately before compared with regular human insulin injected 30 min before a Mediterranean‐style meal in 37 (23 M, 14 F) patients with Type 2 diabetes. 
View on Wiley
ncbi.nlm.nih.gov
55 Citations
Highly Influential Citations
1
Background Citations
10
Methods Citations
3
Results Citations
1

55 Citations

Citation Type

Citation Type

Meta-analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus
  • 16
  • PDF
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.
  • 22
Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices
  • 19
Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight‐based dose of insulin Aspart
  • 3
Insulin therapy in patients with type 2 diabetes mellitus: Treatment to target fasting and postprandial blood glucose levels
  • 12
Brief report A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients
  • 1
Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions
  • 4
Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix®study
  • 21
Insulin aspart for the treatment of Type 2 diabetes
  • 1
Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience
  • 16
  • Highly Influenced
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
  • 171
Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
  • 227
Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin
  • 111
Mealtime glucose regulation in type 2 diabetes.
  • 13
Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus
  • 474
Physiological insulin replacement in type 1 diabetes mellitus.
  • G. Bolli
  • Medicine
  • Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
  • 2001
  • 52
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
  • 2,254
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.
  • 275
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
  • 15,464
  • PDF
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).
  • 1,343
  • PDF
...
1
2
3
...